Live from the NIH registry
Studies recruiting near Syracuse right now
Top 25 of 256 recruiting studies, sorted by proximity — each links to its official registry page
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
SUNY Upstate Medical Center — Syracuse, New York (0.5 mi)
· Sponsor: GT Medical Technologies, Inc.
Lupus Landmark Study: A Prospective Registry and Biorepository
Systemic Lupus Erythematosus (SLE), Lupus Nephritis
N/A
Observational 3,500 participants sought
SUNY Upstate — Syracuse, New York (0.5 mi)
· Sponsor: Lupus Research Alliance
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: NRG Oncology
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Syracuse, New York (0.5 mi)
· Sponsor: Sameek Roychowdhury
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
Phase 3
Interventional 336 participants sought
Hematology Oncology Associates of Central New York-East Syracuse — East Syracuse, New York (3.7 mi)
· Sponsor: National Cancer Institute (NCI)
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: Children's Oncology Group
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
Aortic Valve Stenosis, Aortic Valve Regurgitation
N/A
Interventional 310 participants sought
St-Joseph's Health INC — Syracuse, New York (0.5 mi)
· Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Carcinoma, Non-small-Cell Lung
Phase 2
Interventional 520 participants sought
Hematology-Oncology Associates of CNY — East Syracuse, New York (3.7 mi)
· Sponsor: Janssen Research & Development, LLC
Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for Neck Pain Relief
Neck Pain Musculoskeletal, Neck Pain Treatment
N/A
Interventional 160 participants sought
PROActivePT — Syracuse, New York (0.5 mi)
· Sponsor: Baylor University
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: NRG Oncology
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 1
Interventional 1,394 participants sought
Exelixis Clinical Site #76 — Syracuse, New York (0.5 mi)
· Sponsor: Exelixis
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Migraine
Phase 3
Interventional 1,800 participants sought
Central New York Clinical Research — Manlius, New York (8.8 mi)
· Sponsor: TriGemX Bio, Inc.
A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)
Triple Negative Breast Cancer (TNBC), Elevated Tumor-Infiltrating Lymphocytes
Phase 2
Interventional 55 participants sought
SUNY Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: Medical University of South Carolina
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Pancreatic Carcinoma, Pancreatic Neoplasm
Phase 3
Interventional 274 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: SWOG Cancer Research Network
PEG3350 vs Senna After Urogyn Surgery
Obstructive Defecation Syndrome, Postoperative Constipation
Phase 4
Interventional 254 participants sought
St. Joseph's Health Hospital — Syracuse, New York (0.5 mi)
· Sponsor: St. Joseph's Health, New York
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
SUNY Upstate Cancer Center ( Site 0178) — Syracuse, New York (0.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Metastatic Hormone-sensitive Prostate Cancer
Phase 2
Interventional 150 participants sought
Associated Med Professionals of NY — Syracuse, New York (0.5 mi)
· Sponsor: Novartis Pharmaceuticals
Testing an Adaptive Intervention for Peer-Supported Mobile Health for Primary Care Veterans With Psychological Distress
Psychological Distress
N/A
Interventional 384 participants sought
Syracuse VA Medical Center, Syracuse, NY — Syracuse, New York (0.5 mi)
· Sponsor: VA Office of Research and Development
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: Children's Oncology Group
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Diabetic Nephropathies, Kidney Failure, Chronic
Phase 3
Interventional 150 participants sought
SUNY Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: Alessandro Doria
Educational Discharge Video Impact on Post-Operative Healthcare Utilization After HoLEP
HoLEP, Patient Satisfaction
N/A
Interventional 114 participants sought
Scott SUNY Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: University of California, San Francisco
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Phase 2
Interventional 125 participants sought
Hematology Oncology Associates of Central New York — Camillus, New York (8.1 mi)
· Sponsor: Jazz Pharmaceuticals
Apixaban or Enoxaparin After Head and Neck Cancer Surgery
Venous Thromboembolism, Head and Neck Cancer
Phase 4
Interventional 76 participants sought
SUNY Upstate — Syracuse, New York (0.5 mi)
· Sponsor: Kiranya Arnold